These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11460845)

  • 41. [The role of aspirin in the primary prevention of cardiovascular disease].
    Rodondi N; Cornuz J
    Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The vitamin E debate: implications for ongoing trials of pre-eclampsia prevention.
    Fraser WD; Audibert F; Bujold E; Leduc L; Xu H; Boulvain M; Julien P
    BJOG; 2005 Jun; 112(6):684-8. PubMed ID: 15924519
    [No Abstract]   [Full Text] [Related]  

  • 43. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
    Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
    Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Folate supplementation and cardiovascular disease.
    Stampfer M; Rimm E; Willett W
    Lancet; 2006 Apr; 367(9518):1237-8; author reply 1238-9. PubMed ID: 16631874
    [No Abstract]   [Full Text] [Related]  

  • 45. Women's health research: evidence from two major trials.
    Brandt D
    Am J Nurs; 2005 Nov; 105(11):21. PubMed ID: 16264294
    [No Abstract]   [Full Text] [Related]  

  • 46. Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project.
    J Cardiovasc Risk; 1995 Apr; 2(2):137-42. PubMed ID: 7606650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Baseline characteristics of participants in the Women's Health Study.
    Rexrode KM; Lee IM; Cook NR; Hennekens CH; Buring JE
    J Womens Health Gend Based Med; 2000; 9(1):19-27. PubMed ID: 10718501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aspirin and risk of cardiovascular disease.
    Hennekens CH; Buring JE
    Ration Drug Ther; 1988 Nov; 22(11):1-7. PubMed ID: 3074336
    [No Abstract]   [Full Text] [Related]  

  • 49. Antioxidant strategy for cardiovascular disease.
    Violi F; Micheletta F; Luliano L
    Lancet; 2001 May; 357(9269):1704; author reply 1706. PubMed ID: 11428361
    [No Abstract]   [Full Text] [Related]  

  • 50. Antioxidant strategy for cardiovascular diseases.
    Gensini GF; Conti AA
    Lancet; 2001 May; 357(9269):1704; author reply 1706. PubMed ID: 11428362
    [No Abstract]   [Full Text] [Related]  

  • 51. Low-dose aspirin in primary prevention revisited.
    Pines A
    Climacteric; 2014 Jun; 17(3):310-1. PubMed ID: 24945033
    [No Abstract]   [Full Text] [Related]  

  • 52. Vitamin E in tardive dyskinesia.
    Schneiderhan ME
    Ann Pharmacother; 1993 Mar; 27(3):311-3. PubMed ID: 8453169
    [No Abstract]   [Full Text] [Related]  

  • 53. Antioxidants may retard cataract formation.
    Floren LC; Zangwill AC; Schroeder DJ
    Ann Pharmacother; 1994 Sep; 28(9):1040-2. PubMed ID: 7803880
    [No Abstract]   [Full Text] [Related]  

  • 54. Aspirin and cancer prevention.
    Kurth T
    BMJ; 2012 Apr; 344():e2480. PubMed ID: 22491078
    [No Abstract]   [Full Text] [Related]  

  • 55. Aspirin, flu and general practice research.
    Parsons J
    Aust Fam Physician; 2010 May; 39(5):263. PubMed ID: 20485708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin? Focus on vitamin E and cardiovascular disease.
    Ueda S; Yasunari K
    Curr Pharm Biotechnol; 2006 Apr; 7(2):69-72. PubMed ID: 16724939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suggestion of a dual-functional agent for future trials in nonalcoholic fatty liver disease.
    Shen L
    Hepatology; 2010 Nov; 52(5):1866-7. PubMed ID: 20672381
    [No Abstract]   [Full Text] [Related]  

  • 58. [First WARFASA, now ASPIRE. The new career of ASS in long-term thromboembolism prevention].
    Einecke D
    MMW Fortschr Med; 2012 Nov; 154(20):18. PubMed ID: 23234110
    [No Abstract]   [Full Text] [Related]  

  • 59. Aspirin for Prevention of Cardiovascular Disease.
    Mendy VL; Vargas R; Zhang L
    Prev Chronic Dis; 2017 Sep; 14():E77. PubMed ID: 28880838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antioxidant strategy for cardiovascular diseases.
    Hooper L; Ness AR; Smith GD
    Lancet; 2001 May; 357(9269):1705-6. PubMed ID: 11428363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.